what is the difference between glp-1 and wegovy vs. Ozempic: Important Differences To Consider How GLP-1 medications are transforming

doi: 10.2147/PPA.S277676

That first step is a tolerance dose , not a treatment dose

The rate of antibody formation is quite high in some short-acting or non-human-homologous peptides: Lixisenatide: 69.8% antibody formation incidence Exenatide: 44% antibody formation incidence Liraglutide: 8.6% antibody formation incidence Albiglutide: 4% antibody formation incidence Dulaglutide: 1.6% antibody formation incidence While these antibodies rarely neutralize the therapeutic efficacy of the compound, they can occasionally correlate with localized skin reactions

Hierdoor voelen sommige mensen zich sneller verzadigd en eten zij minder

Immunoreactive bands were analyzed using an ECL detection system (GE Healthcare, Buckinghamshire, UK) and chemiluminescence was detected using a ChemiDoc XRS (Bio-Rad Laboratories)

Looks like you have exceeded the limit to bookmark the image